The Effectiveness of Parecoxib on Inflammatory Cytokines, Prostaglandin Levels, and Visual Analogue Scale Value among Preeclamptic Patients that Undergo Caesarean Section
DOI:
https://doi.org/10.48048/tis.2024.7388Keywords:
Preeclampsia, Parecoxib, Proinflammatory cytokines, IL-1(beta), Visual analogue scaleAbstract
Introduction: Preeclampsia is produced by the maternal immune system and trophoblast proinflammatory cytokines. Effective perioperative analgesics reduce surgery-related pain and inflammation. It explores how parecoxib affects IL-1, IL-6, prostaglandin and VAS in preeclampsia patients who had a spinal anesthesia cesarean. Materials and methods: This experiment uses a 2-group pretest and posttest. Samples were taken consecutively. The study group (n = 18) received parecoxib 40 mg IV bolus every 12 h 4 times and paracetamol 1,000 mg IV infusion every 8 h until 48 h postoperatively, while the control group (n = 18) received placebo NaCl 0.9 % IV bolus every 12 h 4 times and paracetamol 1,000 mg IV drip every 8 to 48 h. Participants’ postoperative pain was assessed by VAS before, 12, 24 and 36 h after surgery. Statistical analysis was conducted on biomolecular examination data, including IL-1β, IL-6, PGE2 and VAS values. Results and discussion: The study group had lower IL-1β levels than the control group, although the difference was not significant (p > 0.05). In the study group, IL-6 levels were 4,782 ± 5,673 lower than in the control group (6,147 ± 5,957). Study group IL-6 levels were higher than control group values, although not significantly (p > 0.05). The study group had lower PGE2 than the control group, but not significantly (p > 0.05). The study group’s mean VAS value was 1.722 ± 1.994, lower than the control group’s 1.833 ± 2.007 and not significant (p > 0.05). The study group had considerably lower VAS values than the control group (p < 0.05). Conclusions: In preeclampsia patients who underwent caesarean delivery under spinal anesthesia, parecoxib administration influences IL-1β levels after 24 h and VAS values after 12 h. It did not affect IL-6 or PGE2 levels in preeclamptic individuals who had spinal anesthesia caesarean sections.
HIGHLIGHTS
- Parecoxib, a powerful analgesic, anti-inflammatory drug and moderately toxic maternal and newborn drug
- Parecoxib has the ability to reduce IL-1β levels after 24 h in preeclampsia patients undergoing cesarean section with spinal anesthesia
- After 12 h, parecoxib has an effect on the pain scale (VAS) values of preeclampsia patients who underwent a caesarean section under spinal anesthesia
GRAPHICAL ABSTRACT
Downloads
Metrics
References
C Huang, K Wei, PMY Lee, G Qin, Y Yu and J Li. Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: National population based cohort study. BMJ 2022; 379, e072157.
CV Ananth, JS Brandt, J Hill, HL Graham, S Grover, M Schuster, HS Patrick and KS Joseph. Historical and recent changes in maternal mortality due to hypertensive disorders in the United States, 1979 to 2018. Hypertension 2021; 78, 1414-22.
CW Ives, R Sinkey, I Rajapreyar, ATN Tita and S Oparil. Preeclampsia - pathophysiology and clinical presentations. J. Am. Coll. Cardiol. 2020; 76, 1690-702.
HP Safitri. 2020, Faktor-faktor yang berhubungan dengan kejadian preeclampsia pada ibu bersalin di rsud arifin achmad kota pekanbaru tahun 2018 (in Indonesian). Ph. D. Dissertation. Riau Ministry of Health Polytechnic, Pekanbaru, Indonesia.
AC Staff. The two-stage placental model of preeclampsia: An update. J. Reprod. Immunol. 2019; 134-135, 1-10.
S Rana, E Lemoine, JP Granger and SA Karumanchi. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res. 2019; 124, 1094-112.
KJ Chang, KM Seow and KH Chen. Preeclampsia: Recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int. J. Environ. Res. Publ. Health 2023; 20, 2994.
R Aggarwal, AK Jain, P Mittal, M Kohli, P Jawanjal and G Rath. Association of pro‐and anti‐inflammatory cytokines in preeclampsia. J. Clin. Lab. Anal. 2019; 33, e22834.
M Michalczyk, A Celewicz, M Celewicz, P Woźniakowska-Gondek and R Rzepka. The role of inflammation in the pathogenesis of preeclampsia. Mediat. Inflamm. 2020; 2020, 3864941.
E Roofthooft, GP Joshi, N Rawal and MVD Velde. PROSPECT guideline for elective caesarean section: Updated systematic review and procedure‐specific postoperative pain management recommendations. Anaesthesia 2021; 76, 665-80.
P Glare, KR Aubrey and PS Myles. Transition from acute to chronic pain after surgery. Lancet 2019; 393, P1537-P1546.
S Kerai, K Saxena and B Taneja. Post-caesarean analgesia: What is new? Indian J. Clin. Anaesth. 2017; 61, 200-14.
P Li, X Zheng, Y Wu and J Peng. The efficacy of parecoxib for pain control after hysterectomy: A meta-analysis of randomized controlled studies. J. Matern. Fetal Neotal Med. 2019; 34, 3488-95.
N Inthigood, T Lertbunnaphong and A Jaishuen. Efficacy of a single 40-mg intravenous dose of parecoxib for postoperative pain control after elective cesarean delivery: A double-blind randomized placebo-controlled trial. J. Obstet. Gynaecol. Res. 2016; 43, 92-9.
A Hurrell, K Duhig, B Vandermolen and AH Shennan. Recent advances in the diagnosis and management of pre-eclampsia. Facul. Rev. 2020; 9, 10.
Siswanto BW, Sudigdo Sastroasmoro. Dasar-dasar Metodologi Penelitian Klinis. Fifth edition. Sagung Seto, Jakarta, 2014.
MR Ahmad and T Bisri. Multimodal analgesic effect on proinflammatory and anti-inflammatory cytokines serum. Int. J. Int. Health Sci. 2014; 2, 15-22.
SM Ogunwole, G Mwinnyaa, X Wang, X Hong, J Henderson and WL Bennett. Preeclampsia across pregnancies and associated risk factors: Findings from a high-risk US birth cohort. J. Am. Heart Assoc. 2021; 10, e019612.
H Fitriani, RA Setya and M Keni. Risk factors of preeclampsia among pregnant women in Indonesia. In: Proceedings of the 4th International Virtual Conference on Nursing, Bandung, Indonesia. 2020.
JJ Sheen, Y Huang, M Andrikopoulou, JD Wright, D Goffman, ME D’Alton and AM Friedman. Maternal age and preeclampsia outcomes during delivery hospitalizations. Am. J. Perinatol. 2020; 37, 44-52.
AM Alvarez, C DeOcesano-Pereira, C Teixeira and V Moreira. IL-1β and TNF-α modulation of proliferated and committed myoblasts: IL-6 and COX-2-derived prostaglandins as key actors in the mechanisms involved. Cells 2020; 9, 2005.
J Chen, X Cong, X Zhan, Z Zhou and W Zheng. Effects of parecoxib on pain threshold and inflammatory factors IL-1β, IL-6 and TNF-α in spinal cord of rats with bone cancer pain. J. Coll. Phys. Surg. Pakistan 2019; 29, 528-31.
RD Wang, JY Zhu, Y Zhu, YS Ge, GL Xu and WD Jia. Perioperative analgesia with parecoxib sodium improves postoperative pain and immune function in patients undergoing hepatectomy for hepatocellular carcinoma. J. Eval. Clin. Pract. 2020; 26, 992-1000.
Y Yang, Q Li, F Tan, J Zhang and W Zhu. Mechanism of IL-8-induced acute lung injury through pulmonary surfactant proteins A and B. Exp. Ther. Med. 2020; 19, 287-93.
S Huang, H Hu, YH Cai and F Hua. Effect of parecoxib in the treatment of postoperative cognitive dysfunction. Medicine 2019; 98, e13812.
L Lu, Y Xie, K Gan and XW Huang. Comparison of intra-articular injection of parecoxib vs oral administration of celecoxib for the clinical efficacy in the treatment of early knee osteoarthritis. World J. Clin. Cases 2019; 7, 3971-9.
R Aouache, L Biquard, D Vaiman and F Miralles. Oxidative stress in preeclampsia and placental diseases. Int. J. Mol. Sci. 2018; 19, 1496.
M Sarengat, RA Ganie and SN Lumbanraja. Levels of interleukin-6 and tumor necrosis factor alpha in pregnant patients with preeclampsia and patients with normal pregnancy. Indonesian J. Clin. Pathol. Med. Lab. 2019; 25, 199-201.
SP Sivarajasingam, N Imami and MR Johnson. Myometrial cytokines and their role in the onset of labour. J. Endocrinol. 2016; 231, R101-R119.
Q Zhuang, L Tao, J Lin, J Jin, W Qian, Y Bian, Y Li, Y Dong, H Peng, Y Li, Y Fan, W Wang, B Feng, N Gao, T Sun, J Lin, M Zhang, S Yan, B Shen, …, X Weng. Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): A multicentre, double-blind, randomised, placebo-controlled trial. BMJ Open 2020; 10, e030501.
C Hong, HY Xie, WK Ge, M Yu, SN Lin and CJ Liu. The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis. Medicine 2022; 101, e30748.
R Horn and J Kramer. Postoperative pain control. StatPearls Publishing, Florida, United States, 2023.
Z Ge, M Li, Y Chen, Y Sun, R Zhang, J Zhang, X Bai, Y Zhang and Q Chen. The efficacy and safety of parecoxib multimodal preemptive analgesia in artificial joint replacement: A systematic review and meta-analysis of randomized controlled trials. Pain Ther. 2023; 12, 1065-78.
JH Wang, T Liu, Y Bai, YQ Chen, YH Cui, XY Gao and JR Guo. The effect of parecoxib sodium on postoperative delirium in elderly patients with hip arthroplasty. Front. Pharmacol. 2023; 14, 947982.
H Salim, MR Ahmad, SK Arif, SH Salam, Z Arrasjid and CW Tan. Perbandingan pemberian ketorolak dengan parecoxib intravena terhadap kadar trombosit, aggregasi trombosit, dan profil koagulasi pada operasi seksio sesarea (in Indonesian). Jurnal Anestesi Perioperatif 2021; 9, 65-75.
MN Essex, H Xu, B Parsons, L Xie and C Li. Parecoxib relieves pain and has an opioid-sparing effect following major gastrointestinal surgery. Int. J. Gen. Med. 2017; 10, 319-27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
